From TD this morning:

Our revised probability-weighted target price ascribes a 70% chance of an
outright sale at $1.50 per share and a 30% chance standalone DCF-derived
fundamental value of $1.30 per share. Our target price increases to $1.45
from $1.30 previously; we reiterate our BUY recommendation.